Taro Pharmaceutical Industries Ltd. (TARO): Price and Financial Metrics

Taro Pharmaceutical Industries Ltd. (TARO): $37.89

0.89 (+2.41%)

POWR Rating

Component Grades

Momentum

D

Stability

B

Sentiment

Quality

C

Add TARO to Watchlist
Sign Up

TARO Price/Volume Stats

Current price $37.89 52-week high $42.22
Prev. close $37.00 52-week low $22.89
Day low $37.13 Volume 28,200
Day high $38.33 Avg. volume 33,772
50-day MA $35.59 Dividend yield N/A
200-day MA $33.85 Market Cap 1.42B

TARO Stock Price Chart Interactive Chart >


Taro Pharmaceutical Industries Ltd. (TARO) Company Bio


Taro Pharmaceutical Industries offers prescription and over-the-counter pharmaceutical products focusing on primary areas, including topical creams and ointments, liquids, capsules, and tablets in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. The company was founded in 1959 and is based in Haifa Bay, Israel.


TARO Latest News Stream


Event/Time News Detail
Loading, please wait...

TARO Latest Social Stream


Loading social stream, please wait...

View Full TARO Social Stream

Latest TARO News From Around the Web

Below are the latest news stories about TARO PHARMACEUTICAL INDUSTRIES LTD that investors may wish to consider to help them evaluate TARO as an investment opportunity.

Taro Provides Results for September 30, 2023

HAWTHORNE, N.Y., October 26, 2023--TARO PROVIDES RESULTS FOR SEPTEMBER 30, 2023

Yahoo | October 26, 2023

Taro Provides Results for the Quarter Ended June 30, 2023

HAWTHORNE, N.Y., July 27, 2023--TARO PROVIDES RESULTS FOR THE QUARTER ENDED JUNE 30, 2023

Yahoo | July 27, 2023

Krensavage Asset Management Opposes Sun's Lowball Bid for Taro

As the largest minority shareholder1 of Taro Pharmaceutical Industries Ltd. (NYSE: TARO), Krensavage Asset Management LLC opposes Sun Pharmaceutical Industries Ltd.'s paltry bid to take Taro private.

Yahoo | July 19, 2023

Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2023

HAWTHORNE, N.Y., June 30, 2023--Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2023

Yahoo | June 30, 2023

Why Shares of Taro Pharmaceutical Are Rising Tuesday

Shares of Taro Pharmaceutical Industries (NYSE: TARO) were up more than 23% Tuesday morning after the company reported late Friday that in a Securities and Exchange Commission (SEC) filing, it was looking at a buyout offer from Sun Pharmaceuticals, India's largest drugmaker. Sun Pharmaceuticals already owns 78.5% of Taro's shares and now plans to buy the remaining 21.5% of the company's shares at $38 a share, at a premium of 31.2% over the stock's closing price of $28.97 on May 25. Taro's directors, in a filing with the SEC, pushed for the move, saying that it would benefit all shareholders of Taro.

Yahoo | May 30, 2023

Read More 'TARO' Stories Here

TARO Price Returns

1-mo 8.54%
3-mo -0.63%
6-mo -7.27%
1-year 30.34%
3-year -47.07%
5-year -57.18%
YTD 30.48%
2022 -42.05%
2021 -31.75%
2020 -16.50%
2019 3.89%
2018 -19.17%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!